Appointment of executive director
Filed with HKEX · Stock code 858 · · 2 pages · English
Summary by 6ix AI
Mr. Wu brings extensive experience in electronic components and supply chain management, having previously held managerial roles in related fields. His remuneration package includes a monthly salary, a year-end bonus, and eligibility for share options, determined by the Board based on his qualifications and market conditions. The Board has welcomed Mr. Wu to his new position and confirmed that he does not hold any other directorships or interests in the Company’s shares.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Extrawell Pharmaceutical Holdings Limited on 6ix
Earlier from Extrawell Pharmaceutical
- Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
- Further extension of long stop date in respect of proposed fourth amendments to the terms and conditions of the bonds
- Extrawell Pharmaceutical Holdings: Proposals for general mandates to issue new shares and buy back shares, re-election of retiring directors and notice of annual general meeting
- Extrawell Pharmaceutical Holdings: Major transaction - second amendments to the terms and conditions of the convertible bonds
- Poll results of annual general meeting held on 28 August 2020 and retirement of director
Later from Extrawell Pharmaceutical
- List of directors and their roles and functions
- Proposed share consolidation; proposed capital Reduction; proposed share sub-division and proposed change in board lot size
- Termination of the memorandum of understanding in relation to the possible sale of the convertible bonds
Follow Extrawell Pharmaceutical into a list and get an email when it puts out news.
Follow Extrawell Pharmaceutical